CrushSCI.com
151.8平均天数
130中位天数
57最短天数
331最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

23 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

161 天

Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review

作者
Ana S. Rodríguez-Báez; Nina Kreuzberger; Claire Iannizzi; Kamran Irfan; Frederike Lentz; Anna Krueger; Norbert Benda; Ulrich Jaehde展开收起
作者单位
1. Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, Bonn, Germany; 2. Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany; 3. Faculty of Medicine and University Hospital Cologne, Institute of Public Health, University of Cologne, Cologne, Germany; 4. National Institute of Research in Agronomy (INRA), Université d´Avignon et des Pays du Vaucluse, UMR Emmah, Avignon, France展开收起
PDF源文件 DOI 网页
159 天

Optimization of Cefotaxime Treatment in Intensive Care Patients: Impact of Inter- and Intra-patient Variability on Pharmacokinetics and Target Attainment

作者
Anthéa Deschamps; Florence Gattacceca; Olivier Blin; Lionel Velly; Romain Guilhaumou展开收起
作者单位
1. Aix Marseille University, APHM, INSERM, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France; 2. COMPutational Pharmacology and Clinical Oncology Department, Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France; 3. Department of Anaesthesiology and Critical Care Medicine, Aix Marseille University, APHM, University Hospital Timone, Marseille, France; 4. Aix Marseille University, CNRS, INT, Institute Neuroscience Timone, UMR7289, Marseille, France; 5. Aix Marseille University, CNRS, INS, Institute Neuroscience Systeme, UMR 1106, Marseille, France展开收起
PDF源文件 DOI 网页
123 天

Clinical Pharmacokinetics and Disposition of Imrecoxib

作者
Shengnan Zhao; Charlie Li; Marlon C. Mallillin; Raimar Löbenberg; Neal M. Davies展开收起
作者单位
1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada; 2. China Z. Pharmaceutical Productivity Centre, Beijing, China; 3. Department of Pharmacy, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines展开收起
PDF源文件 DOI 网页
128 天

Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment

作者
Jingheng Wu; Miaomiao Li; Shuai Wang展开收起
作者单位
1. Department of Functional Neurosurgery of Shengjing Hospital, China Medical University, Shenyang, China; 2. Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China; 3. Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China; 4. Liaoning Clinical Medical Research Center in Nervous System Disease, Shenyang, China; 5. Shenyang, China展开收起
PDF源文件 DOI 网页
57 天

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis

作者
Cassandra Weng-Yan Lai; Suzanne A. M. Wenker; Paul W. Groundwater; Justin Beardsley; Gaurav Sutrave; Ricky Hao Chen; Anne-Grete Märtson; Jan-Willem C. Alffenaar展开收起
作者单位
1. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 2. Faculty of Science, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands; 3. Sydney Institute for Infectious Diseases, University of Sydney, Sydney, Australia; 4. Department of Infectious Diseases, Westmead Hospital, Westmead, Australia; 5. Sydney Medical School-Westmead, University of Sydney, Sydney, Australia; 6. Department of Hematology, Westmead Hospital, Westmead, Australia; 7. Department of Pharmacy, Westmead Hospital, Westmead, Australia展开收起
PDF源文件 DOI 网页
76 天

Exposure–Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma

作者
Mahipal Sinnollareddy; Kinjal Sanghavi; Leonid Gibiansky; Tommy Li; Matthew Putnins; Mohamed-Eslam F. Mohamed; Poliana Patah; Elena Favaro; Manish Gupta; Apurvasena Parikh; Steven Xu展开收起
作者单位
1. Clinical Pharmacology, AbbVie Inc., North Chicago, USA; 2. Clinical Pharmacology, AbbVie Inc., Irvine, USA; 3. Genmab, Plainsboro, USA; 4. QuantPharm LLC, North Potomac, USA; 5. Genmab, Copenhagen, Denmark; 6. Clinical Pharmacology, AbbVie Inc., South San Francisco, USA展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。